Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    P01 - Early Stage/Localized Disease/Ablative Therapies - Adjuvant Therapy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease/Ablative Therapies
    • +

      P01.01 - LIBRETTO-432: A Placebo-Controlled Phase 3 Study of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion-Positive NSCLC

      00:00 - 00:00  |  Presenter: Jonathan Goldman

      • Abstract

      Loading...

  • +

    P53 - Novel Therapeutics and Targeted Therapies - Others

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      P53.02 - Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase (TRK) Fusion-Positive Lung Cancer

      00:00 - 00:00  |  Presenter: Alexander Drilon

      • Abstract

      Loading...

  • +

    IS10 - Satellite CME Symposium by Research To Practice: Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer and Validated Targets Beyond EGFR

    • 05:45 - 06:45
    • 9/10/2021
    • Location: Program Auditorium
    • CME Accredited by Other Provider
    • Type: Satellite CME Symposia
    • Track: N.A.
    • +

      IS10.01 - MODULE 1: Selection and Sequencing of Therapy for Patients with Non-Small Cell Lung Cancer (NSCLC) and an ALK Rearrangement

      05:45 - 06:00

      • Abstract

      No abstract available for this presentation

    • +

      IS10.02 - MODULE 2: Current and Future Directions in the Management of ROS1-Positive NSCLC

      06:00 - 06:15

      • Abstract

      No abstract available for this presentation

    • +

      IS10.03 - MODULE 3: Optimal Use of Recently Approved RET Inhibitors in the Care of Patients with RET-Positive NSCLC

      06:15 - 06:30

      • Abstract

      No abstract available for this presentation

    • +

      IS10.04 - MODULE 4: Rational Approaches to Targeting MET Abnormalities for Patients with NSCLC

      06:30 - 06:45

      • Abstract

      No abstract available for this presentation

  • +

    OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic

    • 20:00 - 21:00
    • 9/12/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Nursing and Allied Health Professionals
    • +

      OA17.04 - The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers

      20:30 - 20:40  |  Presenter: Anne-Marie Baird

      • Abstract

      Loading...